{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=11100&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=11060&ordering=-accession","results":[{"accession":"CLO:0031928","name":"GM14855 cell","definition":"[' CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS']","term_type":"cell line"},{"accession":"CLO:0031927","name":"GM14854 cell","definition":"[' CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS']","term_type":"cell line"},{"accession":"CLO:0031926","name":"GM14871 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0031925","name":"GM14870 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0031924","name":"GM14869 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0031923","name":"GM14867 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0031922","name":"GM14864 cell","definition":"[' NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE']","term_type":"cell line"},{"accession":"CLO:0031921","name":"GM14863 cell","definition":"[' APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS']","term_type":"cell line"},{"accession":"CLO:0031920","name":"GM14717 cell","definition":"[' NEURONAL INTRANUCLEAR INCLUSION DISEASE']","term_type":"cell line"},{"accession":"CLO:0031919","name":"GM14720 cell","definition":"[' APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS']","term_type":"cell line"},{"accession":"CLO:0031918","name":"GM14728 cell","definition":"[' LEOPARD SYNDROME']","term_type":"cell line"},{"accession":"CLO:0031917","name":"GM14732 cell","definition":"[' ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0031916","name":"GM14729 cell","definition":"[' LEOPARD SYNDROME']","term_type":"cell line"},{"accession":"CLO:0031915","name":"GM14734 cell","definition":"[' ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0031914","name":"GM14733 cell","definition":"[' ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0031913","name":"GM14753 cell","definition":"[' APPARENTLY HEALTHY NON-FETAL TISSUE']","term_type":"cell line"},{"accession":"CLO:0031912","name":"GM14746 cell","definition":"[' NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE']","term_type":"cell line"},{"accession":"CLO:0031911","name":"GM14755 cell","definition":"[' APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS']","term_type":"cell line"},{"accession":"CLO:0031910","name":"GM14754 cell","definition":"[' APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS']","term_type":"cell line"},{"accession":"CLO:0031909","name":"ND09620 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"}]}